MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2022-23)
- Udyam number
- UDYAM-TS-20-0008175
Srikar Laboratories Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹72.62 Cr
▼ 10% YoY
Net profit · FY 2025
₹3.55 Cr
Net margin 4.9%
EBITDA · FY 2025
₹9.31 Cr
EBITDA margin 12.8%
Authorised capital
₹6.99 Cr
Registered with MCA
Paid-up capital
₹6.99 Cr
Issued & subscribed
Open charges
₹27.21 Cr
Satisfied ₹17.25 Cr
Company age
15 yrs
Est. 2011
Employees · EPFO
144
Provident fund records
About Srikar Laboratories Private Limited
Data last updated:
Srikar Laboratories Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 February 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2011PTC072844. Its GSTIN is 37AAQCS3754A1Z8 (Andhra Pradesh).
The company has an authorised share capital of ₹6.99 Cr and a paid-up capital of ₹6.99 Cr. It is led by directors including Vijender Medamoni (Managing Director) and Murali Krishnam Raju Vadlamudi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F No.103 1 – 2 – 10/4/103 Evr Shraddha Enclave Apts. Street No.2 Kakatiya Nagar Habsiguda, Hyderabad, Telangana, India – 500007.
As per the financials filed for FY 2025, the company reported a revenue of ₹72.62 Cr, a decline of 10% compared to the previous year. For the same year it recorded a net profit of ₹3.55 Cr (net margin 4.9%) and EBITDA of ₹9.31 Cr (EBITDA margin 12.8%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 9% over five years.
The company has about 144 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: SRIKAR Labs. As per MCA filings, the company has open charges of ₹27.21 Cr and satisfied charges of ₹17.25 Cr on record. Court records list 15 cases involving the company, including 1 filed by the company and 14 filed against it; 7 cases are pending. The company has 10 deals on record (8 secondary share transfers, 2 funding rounds), with disclosed funding of ₹6 Cr; the latest was in December 2023. Its 6 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 3 smaller; the largest is Shiva Biogenetic Laboratories Private Limited with revenue of ₹73.64 Cr.
Srikar Laboratories Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0008175). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website srikarlabs.com.
Company details
CIN U24100TG2011PTC072844
Registration Number 072844
Incorporation Date 23 February 2011
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-20-0008175
CIN history
Srikar Laboratories has one previous CIN (Corporate Identification Number): U24100AP2011PTC072844. The current CIN is U24100TG2011PTC072844, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100TG2011PTC072844 | Current |
| U24100AP2011PTC072844 | Previous |
Key People
Vijender Medamoni Managing Director Murali Krishnam Raju Vadlamudi Director Satyanarayana Raju Kanteti Director Recognitions & Rankings of Srikar Laboratories
Contact details
Srikar Laboratories Private Limited's registered office is in Hyderabad, Telangana. Its website is srikarlabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressF No.103 1 – 2 – 10/4/103 Evr Shraddha Enclave Apts. Street No.2 Kakatiya Nagar Habsiguda, Hyderabad, Telangana, India – 500007
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Srikar Laboratories Private Limited, buy the company report.
Comprehensive company report
Srikar Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Srikar Laboratories operates one associated brand: SRIKAR Labs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical API manufacturing and contract services in India. | srikarlabs.com |
Business activity
The main business activity of Srikar Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Srikar Laboratories Private Limited, buy the company report.
Financials of Srikar Laboratories Private Limited
FY 2025 filings availableSrikar Laboratories Private Limited reported revenue of ₹72.62 Cr (down 10% YoY) for FY 2025.
Revenue · FY 2025
₹72.62 Cr ▼ 10%
Net profit · FY 2025
₹3.55 Cr margin 4.9%
EBITDA · FY 2025
₹9.31 Cr margin 12.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 10%
3 years · compounded
▲ 4%
5 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▲ 29%
3 years · compounded
▲ 20%
5 years · compounded
▲ 20%
Revenue fell 10% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 9%. EBITDA rose 29% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.31 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.55 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.8% | ||||
| Net Profit Margin | 4.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Srikar Laboratories Private Limited, buy the company report.
Board of directors of Srikar Laboratories Private Limited
Srikar Laboratories has 4 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Murali Krishnam Raju Vadlamudi Also directs: KRR Drugs and Chemicals Private Limited | Director | 23 Feb 2011 | 15 Years 8 Months | Current |
| Satyanarayana Raju Kanteti | Director | 30 Nov 2020 | 5 Years 11 Months | Current |
| Sandeep Reddy Veerlapally | Director | 19 Nov 2022 | 3 Years 11 Months | Current |
| Vijender Medamoni | Managing Director | 04 Aug 2025 | 1 Years 3 Months | Current |
Peer comparison
Srikar Laboratories Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shiva Biogenetic Laboratories Private Limited | ₹73.64 Cr (FY 2025) | 2.0% | Baddi, Himachal Pradesh, India | |||
| Avn Ayurveda Formulations Private Limited | ₹72.9 Cr (FY 2025) | 6.0% | Madurai, Tamil Nadu, India | |||
| Eskay Herbal Formulations Private Limited | ₹72.88 Cr (FY 2025) | -3.0% | Jalgaon, Maharashtra, India | |||
| Srikar Laboratories Private Limitedthis company | ₹72.62 Cr (FY 2025) | ₹3.55 Cr | 4.9% | -10.0% | 144 | Hyderabad, Telangana, India |
| Elan Pharma (India) Private Limited | ₹72.61 Cr (FY 2025) | 12.0% | Mumbai, Maharashtra, India | |||
| Vance and Health Pharmaceuticals Private Limited | ₹72.08 Cr (FY 2025) | 17.0% | Hyderabad, Telangana, India | |||
| Walpar Nutritions Limited | ₹72.03 Cr (FY 2025) | 15.0% | Gandhinagar, Gujarat, India |
To see the full peer comparison of Srikar Laboratories Private Limited, buy the company report.
Auditor
Srikar Laboratories Private Limited is audited by Vennapusa & Sunkara for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Vennapusa & Sunkara | FY 2023 | 012147S |
Shareholding
The shareholding of Srikar Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Srikar Laboratories Private Limited, buy the company report.
Charges & borrowings
Open charges
₹27.21 Cr
Satisfied charges
₹17.25 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Aug 2019 | 100286796 | Hdfc Bank Limited | ₹27.21 Cr | Open | |
| 31 Oct 2016 | 100059466 | Others | ₹50 Lakh | Satisfied | |
| 30 Dec 2011 | 10331346 | Others | ₹16.75 Cr | Satisfied |
To see the full charge records of Srikar Laboratories Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Srikar Laboratories Private Limited has 10 deals on record (8 secondary share transfers, 2 funding rounds), with disclosed funding of ₹6 Cr; the latest was in December 2023.
Total deals
10
Secondary share transfers
8
Funding rounds
2
Disclosed funding
₹6 Cr
Deals on record (5 of 10)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2021 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: Keminntek Pharmaceuticals LLP |
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: Keminntek Pharmaceuticals LLP & Vadlamudi Murali Krishnam Raju, Keminntek Pharmaceuticals LLP Seller: 2 individuals |
| May 2020 | Secondary share transfer | Undisclosed | Buyer: Keminntek Pharmaceuticals LLP Seller: an individual |
| May 2020 | Secondary share transfer | Undisclosed | Buyer: Keminntek Pharmaceuticals LLP Seller: 4 individuals |
| Mar 2020 | Secondary share transfer | Undisclosed | Buyer: Keminntek Pharmaceuticals LLP Seller: 4 individuals |
To see the full deal history of Srikar Laboratories Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Srikar Laboratories Private Limited has 15 court cases on record: 1 filed by Srikar Laboratories, 14 filed against it. 7 cases are pending and 8 are disposed.
Total cases
15
Filed by the company
1
Filed against the company
14
Pending
7
Disposed
8
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 14 | 14 | 7 |
| High courts | 1 | 0 | 0 |
Cases on record (5 of 15)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Court case (Com.O.S.) | Filed against the company by Cocreate Global Technologies Private Limited | Disposed |
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against Eastern Power Distribution Company of Andhra Pradesh Ltd,. and 1 other | Disposed |
| District court, Hyderabad Central, Telangana | Court case (CC - NI) | Filed against the company by M/S Sesa Chem India Pvt. Ltd., Rep.By Mr.Ankit Vijaywargia, S/O. Mukesh Vijaywargia | Disposed |
| District court, Bharuch, Gujarat | Civil suit | Filed against the company by Organic Industries Pvt Ltd Through Its A.R.,Mr,Hiren Gandhi | Disposed |
| District court, Hyderabad Central, Telangana | Criminal complaint | Filed against the company by M/S Sesa Chem India Pvt. Ltd., Rep.By Mr.Ankit Vijaywargia, S/O. Mukesh Vijaywargia | Disposed |
To see the full case history of Srikar Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Srikar Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Srikar Laboratories Private Limited has a workforce of 144 employees on its EPFO records as of Apr 2026, across 1 active EPFO establishment.
Employee count
144
Active EPFO establishments
1
Employee growth
-7.1%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 144 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Srikar Laboratories Private Limited, buy the company report.
GST
Srikar Laboratories has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAQCS3754A1Z8 | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Srikar Laboratories Private Limited, buy the company report.
Recent activity
Srikar Laboratories Private Limited has 22 board changes on record since 2011: 13 appointments and 9 cessations. The latest: Vijender Medamoni was appointed as Managing Director on 04 Aug 2025.
AGM
Srikar Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Appointed
Vijender Medamoni was appointed as Managing Director.
Filing
Srikar Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Hdfc Bank Limited of Rs. 27.21 Cr registered on 22 Aug 2019 with Charge ID 100286796 was modified on 13 Sep 2023.
Ceased
Sreenivas Peddolla ceased to be Whole-Time Director.
Ceased
Srinivas Kolupula ceased to be Managing Director.
Appointed
Sandeep Reddy Veerlapally was appointed as Director.
Charges
A charge registered on 31 Oct 2016 via Charge ID 100059466 with Others was fully satisfied on 27 May 2022.
Ceased
Rami Reddy Kesari ceased to be Director.
Ceased
Venkata Satyanarayana Raju Pathapati ceased to be Director.
Ceased
Apparao Pudi ceased to be Director.
Appointed
Satyanarayana Raju Kanteti was appointed as Director.
20 earlier events are in the company report.
Frequently asked questions
Srikar Laboratories is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 February 2011 (15+ years old) and is registered under CIN U24100TG2011PTC072844.
Srikar Laboratories has 4 current directors:
- Vijender Medamoni - Managing Director
- Murali Krishnam Raju Vadlamudi - Director
- Satyanarayana Raju Kanteti - Director
- Sandeep Reddy Veerlapally - Director
The latest financial statements of Srikar Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Srikar Laboratories is 37AAQCS3754A1Z8, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Srikar Laboratories is U24100TG2011PTC072844. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Srikar Laboratories has 15 court cases on record: 1 filed by the company and 14 filed against it. 7 are pending. Most are in the district courts.
Srikar Laboratories was incorporated on 23 February 2011, making it 15+ years old. It is registered with the Registrar of Companies, Hyderabad.
Srikar Laboratories has 10 deals on record (8 secondary share transfers, 2 funding rounds), with disclosed funding of ₹6 Cr; the latest was in December 2023.
The peers of Srikar Laboratories by revenue are Shiva Biogenetic Laboratories Private Limited, Avn Ayurveda Formulations Private Limited, Eskay Herbal Formulations Private Limited, Elan Pharma (India) Private Limited, Vance and Health Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Vijender Medamoni was appointed as Managing Director on 04 Aug 2025. Sreenivas Peddolla ceased to be Whole-Time Director on 17 Mar 2023. Srinivas Kolupula ceased to be Managing Director on 17 Mar 2023. Srikar Laboratories has 22 board changes on record in total.
Yes, Srikar Laboratories is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-20-0008175).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages